nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP2C8—Tazarotene—psoriasis	0.123	0.203	CbGbCtD
Fenofibrate—CYP2C8—Cholecalciferol—psoriasis	0.0525	0.0865	CbGbCtD
Fenofibrate—CYP2C8—Mycophenolate mofetil—psoriasis	0.0456	0.075	CbGbCtD
Fenofibrate—CYP3A4—Calcitriol—psoriasis	0.0414	0.0681	CbGbCtD
Fenofibrate—CYP2C9—Cholecalciferol—psoriasis	0.0366	0.0603	CbGbCtD
Fenofibrate—CYP2C8—Hydrocortisone—psoriasis	0.0366	0.0602	CbGbCtD
Fenofibrate—CYP2C8—Cyclosporine—psoriasis	0.0345	0.0568	CbGbCtD
Fenofibrate—CYP3A4—Methoxsalen—psoriasis	0.0322	0.0529	CbGbCtD
Fenofibrate—CYP2C9—Cyclosporine—psoriasis	0.0241	0.0396	CbGbCtD
Fenofibrate—CYP2C8—Dexamethasone—psoriasis	0.0227	0.0374	CbGbCtD
Fenofibrate—CYP3A4—Cholecalciferol—psoriasis	0.0213	0.0351	CbGbCtD
Fenofibrate—CYP3A4—Mycophenolate mofetil—psoriasis	0.0185	0.0304	CbGbCtD
Fenofibrate—CYP3A4—Triamcinolone—psoriasis	0.0185	0.0304	CbGbCtD
Fenofibrate—CYP2C9—Dexamethasone—psoriasis	0.0159	0.0261	CbGbCtD
Fenofibrate—CYP3A4—Betamethasone—psoriasis	0.0159	0.0261	CbGbCtD
Fenofibrate—CYP3A4—Prednisolone—psoriasis	0.0156	0.0257	CbGbCtD
Fenofibrate—CYP3A4—Hydrocortisone—psoriasis	0.0148	0.0244	CbGbCtD
Fenofibrate—CYP3A4—Prednisone—psoriasis	0.0148	0.0243	CbGbCtD
Fenofibrate—CYP3A4—Cyclosporine—psoriasis	0.014	0.023	CbGbCtD
Fenofibrate—CYP3A4—Dexamethasone—psoriasis	0.00922	0.0152	CbGbCtD
Fenofibrate—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00331	0.0542	CbGpPWpGaD
Fenofibrate—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.0027	0.0441	CbGpPWpGaD
Fenofibrate—PPARA—REV-ERBA represses gene expression—CARM1—psoriasis	0.00267	0.0437	CbGpPWpGaD
Fenofibrate—PPARA—RORA activates circadian gene expression—CARM1—psoriasis	0.00259	0.0423	CbGpPWpGaD
Fenofibrate—PPARA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—CARM1—psoriasis	0.0023	0.0376	CbGpPWpGaD
Fenofibrate—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.00205	0.0336	CbGpPWpGaD
Fenofibrate—Indomethacin—CXCL8—psoriasis	0.00191	0.381	CrCbGaD
Fenofibrate—PPARA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	0.00189	0.0309	CbGpPWpGaD
Fenofibrate—PPARA—Activation of gene expression by SREBF (SREBP)—CARM1—psoriasis	0.00178	0.029	CbGpPWpGaD
Fenofibrate—Bezafibrate—PPARG—psoriasis	0.00178	0.355	CrCbGaD
Fenofibrate—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.00167	0.0273	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional activation of mitochondrial biogenesis—CARM1—psoriasis	0.00162	0.0264	CbGpPWpGaD
Fenofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.0015	0.0245	CbGpPWpGaD
Fenofibrate—PPARA—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CARM1—psoriasis	0.00142	0.0232	CbGpPWpGaD
Fenofibrate—PPARA—Mitochondrial biogenesis—CARM1—psoriasis	0.0014	0.0228	CbGpPWpGaD
Fenofibrate—PPARA—Circadian Clock—CARM1—psoriasis	0.00138	0.0225	CbGpPWpGaD
Fenofibrate—Indomethacin—PPARG—psoriasis	0.00132	0.263	CrCbGaD
Fenofibrate—PPARA—Estrogen Receptor Pathway—JUN—psoriasis	0.00129	0.0211	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00121	0.0197	CbGpPWpGaD
Fenofibrate—PPARA—Estrogen Receptor Pathway—STAT3—psoriasis	0.00111	0.0182	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors—VDR—psoriasis	0.0011	0.0181	CbGpPWpGaD
Fenofibrate—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.0011	0.018	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—CARM1—psoriasis	0.00105	0.0172	CbGpPWpGaD
Fenofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.00104	0.0171	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000873	0.0143	CbGpPWpGaD
Fenofibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000853	0.0139	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000842	0.0138	CbGpPWpGaD
Fenofibrate—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000841	0.0138	CbGpPWpGaD
Fenofibrate—PPARA—Orphan transporters—CARM1—psoriasis	0.000827	0.0135	CbGpPWpGaD
Fenofibrate—PPARA—PPARA activates gene expression—CARM1—psoriasis	0.000791	0.0129	CbGpPWpGaD
Fenofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000774	0.0127	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors—PPARG—psoriasis	0.00077	0.0126	CbGpPWpGaD
Fenofibrate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000694	0.0113	CbGpPWpGaD
Fenofibrate—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000691	0.0113	CbGpPWpGaD
Fenofibrate—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000685	0.0112	CbGpPWpGaD
Fenofibrate—PPARA—Organelle biogenesis and maintenance—CARM1—psoriasis	0.000634	0.0104	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000609	0.00995	CbGpPWpGaD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000563	0.0092	CbGpPWpGaD
Fenofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000554	0.00906	CbGpPWpGaD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000533	0.00872	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—LEP—psoriasis	0.000503	0.00822	CbGpPWpGaD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000458	0.00748	CbGpPWpGaD
Fenofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000452	0.00739	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—SOCS1—psoriasis	0.000448	0.00733	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—PPARG—psoriasis	0.000438	0.00716	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—TARS—psoriasis	0.000386	0.00632	CbGpPWpGaD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000371	0.00607	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000367	0.006	CbGpPWpGaD
Fenofibrate—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000366	0.00599	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000362	0.00592	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—LEP—psoriasis	0.000331	0.00541	CbGpPWpGaD
Fenofibrate—PPARA—PPARA activates gene expression—PPARG—psoriasis	0.000329	0.00538	CbGpPWpGaD
Fenofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	0.000322	0.00527	CbGpPWpGaD
Fenofibrate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000319	0.00521	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—NFKB1—psoriasis	0.000299	0.00489	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000299	0.00489	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000295	0.00482	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—PPARG—psoriasis	0.000288	0.00471	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—CARM1—psoriasis	0.000253	0.00413	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—CARM1—psoriasis	0.000238	0.00389	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—LEP—psoriasis	0.000233	0.00381	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—TNF—psoriasis	0.000233	0.0038	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—NDUFA5—psoriasis	0.000228	0.00372	CbGpPWpGaD
Fenofibrate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000222	0.00363	CbGpPWpGaD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	0.000222	0.00363	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—NOS2—psoriasis	0.000217	0.00355	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000212	0.00347	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—CP—psoriasis	0.000212	0.00346	CbGpPWpGaD
Fenofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00021	0.00344	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—PPARG—psoriasis	0.000203	0.00332	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—CARM1—psoriasis	0.000202	0.0033	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000197	0.00322	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000194	0.00318	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP2S1—psoriasis	0.000194	0.00317	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—STAT3—psoriasis	0.000177	0.00289	CbGpPWpGaD
Fenofibrate—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.00017	0.00278	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—TNF—psoriasis	0.000153	0.0025	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—VDR—psoriasis	0.000151	0.00247	CbGpPWpGaD
Fenofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000147	0.0024	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—JUN—psoriasis	0.000144	0.00236	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—IL6—psoriasis	0.000123	0.00202	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—CARM1—psoriasis	0.000122	0.00199	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—LEP—psoriasis	0.000114	0.00186	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—PPARG—psoriasis	0.000105	0.00172	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000101	0.00166	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—PPARG—psoriasis	9.9e-05	0.00162	CbGpPWpGaD
Fenofibrate—Mental disorder—Prednisone—psoriasis	9.61e-05	0.000295	CcSEcCtD
Fenofibrate—Erythema—Prednisone—psoriasis	9.55e-05	0.000293	CcSEcCtD
Fenofibrate—Malnutrition—Prednisone—psoriasis	9.55e-05	0.000293	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Hydrocortisone—psoriasis	9.55e-05	0.000293	CcSEcCtD
Fenofibrate—Hyperhidrosis—Triamcinolone—psoriasis	9.54e-05	0.000292	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—TP53—psoriasis	9.51e-05	0.00156	CbGpPWpGaD
Fenofibrate—Feeling abnormal—Mycophenolate mofetil—psoriasis	9.48e-05	0.000291	CcSEcCtD
Fenofibrate—Insomnia—Hydrocortisone—psoriasis	9.48e-05	0.000291	CcSEcCtD
Fenofibrate—Hypertension—Betamethasone—psoriasis	9.47e-05	0.00029	CcSEcCtD
Fenofibrate—Hypertension—Dexamethasone—psoriasis	9.47e-05	0.00029	CcSEcCtD
Fenofibrate—PPARA—Metabolism—CARM1—psoriasis	9.46e-05	0.00155	CbGpPWpGaD
Fenofibrate—Paraesthesia—Hydrocortisone—psoriasis	9.41e-05	0.000288	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	9.4e-05	0.000288	CcSEcCtD
Fenofibrate—Urticaria—Cyclosporine—psoriasis	9.37e-05	0.000287	CcSEcCtD
Fenofibrate—Myalgia—Betamethasone—psoriasis	9.34e-05	0.000286	CcSEcCtD
Fenofibrate—Myalgia—Dexamethasone—psoriasis	9.34e-05	0.000286	CcSEcCtD
Fenofibrate—Abdominal pain—Cyclosporine—psoriasis	9.32e-05	0.000286	CcSEcCtD
Fenofibrate—Body temperature increased—Cyclosporine—psoriasis	9.32e-05	0.000286	CcSEcCtD
Fenofibrate—Anxiety—Betamethasone—psoriasis	9.31e-05	0.000285	CcSEcCtD
Fenofibrate—Anxiety—Dexamethasone—psoriasis	9.31e-05	0.000285	CcSEcCtD
Fenofibrate—Vomiting—Mycophenolic acid—psoriasis	9.27e-05	0.000284	CcSEcCtD
Fenofibrate—Discomfort—Dexamethasone—psoriasis	9.23e-05	0.000283	CcSEcCtD
Fenofibrate—Discomfort—Betamethasone—psoriasis	9.23e-05	0.000283	CcSEcCtD
Fenofibrate—Dyspepsia—Hydrocortisone—psoriasis	9.22e-05	0.000283	CcSEcCtD
Fenofibrate—Rash—Mycophenolic acid—psoriasis	9.19e-05	0.000282	CcSEcCtD
Fenofibrate—Dermatitis—Mycophenolic acid—psoriasis	9.18e-05	0.000281	CcSEcCtD
Fenofibrate—Pain—Prednisolone—psoriasis	9.17e-05	0.000281	CcSEcCtD
Fenofibrate—Hepatitis—Methotrexate—psoriasis	9.17e-05	0.000281	CcSEcCtD
Fenofibrate—Urticaria—Mycophenolate mofetil—psoriasis	9.14e-05	0.00028	CcSEcCtD
Fenofibrate—Headache—Mycophenolic acid—psoriasis	9.13e-05	0.00028	CcSEcCtD
Fenofibrate—Decreased appetite—Hydrocortisone—psoriasis	9.11e-05	0.000279	CcSEcCtD
Fenofibrate—Pharyngitis—Methotrexate—psoriasis	9.1e-05	0.000279	CcSEcCtD
Fenofibrate—Body temperature increased—Mycophenolate mofetil—psoriasis	9.09e-05	0.000279	CcSEcCtD
Fenofibrate—Abdominal pain—Mycophenolate mofetil—psoriasis	9.09e-05	0.000279	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Hydrocortisone—psoriasis	9.05e-05	0.000277	CcSEcCtD
Fenofibrate—Fatigue—Hydrocortisone—psoriasis	9.03e-05	0.000277	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Triamcinolone—psoriasis	8.99e-05	0.000276	CcSEcCtD
Fenofibrate—Pain—Hydrocortisone—psoriasis	8.96e-05	0.000275	CcSEcCtD
Fenofibrate—Oedema—Dexamethasone—psoriasis	8.95e-05	0.000274	CcSEcCtD
Fenofibrate—Oedema—Betamethasone—psoriasis	8.95e-05	0.000274	CcSEcCtD
Fenofibrate—Insomnia—Triamcinolone—psoriasis	8.92e-05	0.000274	CcSEcCtD
Fenofibrate—Infection—Betamethasone—psoriasis	8.89e-05	0.000273	CcSEcCtD
Fenofibrate—Infection—Dexamethasone—psoriasis	8.89e-05	0.000273	CcSEcCtD
Fenofibrate—Ill-defined disorder—Prednisone—psoriasis	8.86e-05	0.000272	CcSEcCtD
Fenofibrate—Paraesthesia—Triamcinolone—psoriasis	8.86e-05	0.000272	CcSEcCtD
Fenofibrate—Feeling abnormal—Prednisolone—psoriasis	8.84e-05	0.000271	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.84e-05	0.00145	CbGpPWpGaD
Fenofibrate—Visual impairment—Methotrexate—psoriasis	8.84e-05	0.000271	CcSEcCtD
Fenofibrate—Anaemia—Prednisone—psoriasis	8.83e-05	0.000271	CcSEcCtD
Fenofibrate—Dyspnoea—Triamcinolone—psoriasis	8.8e-05	0.00027	CcSEcCtD
Fenofibrate—Nervous system disorder—Betamethasone—psoriasis	8.78e-05	0.000269	CcSEcCtD
Fenofibrate—Nervous system disorder—Dexamethasone—psoriasis	8.78e-05	0.000269	CcSEcCtD
Fenofibrate—Thrombocytopenia—Betamethasone—psoriasis	8.76e-05	0.000269	CcSEcCtD
Fenofibrate—Thrombocytopenia—Dexamethasone—psoriasis	8.76e-05	0.000269	CcSEcCtD
Fenofibrate—Tachycardia—Betamethasone—psoriasis	8.74e-05	0.000268	CcSEcCtD
Fenofibrate—Tachycardia—Dexamethasone—psoriasis	8.74e-05	0.000268	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—IL6—psoriasis	8.71e-05	0.00142	CbGpPWpGaD
Fenofibrate—Hypersensitivity—Cyclosporine—psoriasis	8.69e-05	0.000266	CcSEcCtD
Fenofibrate—Dyspepsia—Triamcinolone—psoriasis	8.68e-05	0.000266	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—TYK2—psoriasis	8.67e-05	0.00142	CbGpPWpGaD
Fenofibrate—Nausea—Mycophenolic acid—psoriasis	8.66e-05	0.000265	CcSEcCtD
Fenofibrate—Hyperhidrosis—Dexamethasone—psoriasis	8.65e-05	0.000265	CcSEcCtD
Fenofibrate—Hyperhidrosis—Betamethasone—psoriasis	8.65e-05	0.000265	CcSEcCtD
Fenofibrate—Feeling abnormal—Hydrocortisone—psoriasis	8.63e-05	0.000265	CcSEcCtD
Fenofibrate—Malaise—Prednisone—psoriasis	8.61e-05	0.000264	CcSEcCtD
Fenofibrate—Vertigo—Prednisone—psoriasis	8.58e-05	0.000263	CcSEcCtD
Fenofibrate—Eye disorder—Methotrexate—psoriasis	8.57e-05	0.000263	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Hydrocortisone—psoriasis	8.57e-05	0.000263	CcSEcCtD
Fenofibrate—Anorexia—Dexamethasone—psoriasis	8.53e-05	0.000262	CcSEcCtD
Fenofibrate—Anorexia—Betamethasone—psoriasis	8.53e-05	0.000262	CcSEcCtD
Fenofibrate—Urticaria—Prednisolone—psoriasis	8.52e-05	0.000261	CcSEcCtD
Fenofibrate—Cardiac disorder—Methotrexate—psoriasis	8.51e-05	0.000261	CcSEcCtD
Fenofibrate—Fatigue—Triamcinolone—psoriasis	8.51e-05	0.000261	CcSEcCtD
Fenofibrate—Hypersensitivity—Mycophenolate mofetil—psoriasis	8.47e-05	0.00026	CcSEcCtD
Fenofibrate—Asthenia—Cyclosporine—psoriasis	8.46e-05	0.000259	CcSEcCtD
Fenofibrate—Pain—Triamcinolone—psoriasis	8.44e-05	0.000259	CcSEcCtD
Fenofibrate—Hypotension—Betamethasone—psoriasis	8.36e-05	0.000256	CcSEcCtD
Fenofibrate—Hypotension—Dexamethasone—psoriasis	8.36e-05	0.000256	CcSEcCtD
Fenofibrate—Pruritus—Cyclosporine—psoriasis	8.34e-05	0.000256	CcSEcCtD
Fenofibrate—Urticaria—Hydrocortisone—psoriasis	8.32e-05	0.000255	CcSEcCtD
Fenofibrate—Angiopathy—Methotrexate—psoriasis	8.32e-05	0.000255	CcSEcCtD
Fenofibrate—Body temperature increased—Hydrocortisone—psoriasis	8.28e-05	0.000254	CcSEcCtD
Fenofibrate—Abdominal pain—Hydrocortisone—psoriasis	8.28e-05	0.000254	CcSEcCtD
Fenofibrate—Mediastinal disorder—Methotrexate—psoriasis	8.26e-05	0.000253	CcSEcCtD
Fenofibrate—Asthenia—Mycophenolate mofetil—psoriasis	8.25e-05	0.000253	CcSEcCtD
Fenofibrate—Hypertension—Prednisone—psoriasis	8.25e-05	0.000253	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Dexamethasone—psoriasis	8.16e-05	0.00025	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Betamethasone—psoriasis	8.16e-05	0.00025	CcSEcCtD
Fenofibrate—Pruritus—Mycophenolate mofetil—psoriasis	8.14e-05	0.000249	CcSEcCtD
Fenofibrate—Arthralgia—Prednisone—psoriasis	8.13e-05	0.000249	CcSEcCtD
Fenofibrate—Myalgia—Prednisone—psoriasis	8.13e-05	0.000249	CcSEcCtD
Fenofibrate—Feeling abnormal—Triamcinolone—psoriasis	8.13e-05	0.000249	CcSEcCtD
Fenofibrate—Anxiety—Prednisone—psoriasis	8.1e-05	0.000248	CcSEcCtD
Fenofibrate—Alopecia—Methotrexate—psoriasis	8.1e-05	0.000248	CcSEcCtD
Fenofibrate—Insomnia—Betamethasone—psoriasis	8.1e-05	0.000248	CcSEcCtD
Fenofibrate—Insomnia—Dexamethasone—psoriasis	8.1e-05	0.000248	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	8.08e-05	0.000248	CcSEcCtD
Fenofibrate—Diarrhoea—Cyclosporine—psoriasis	8.07e-05	0.000247	CcSEcCtD
Fenofibrate—Paraesthesia—Betamethasone—psoriasis	8.04e-05	0.000246	CcSEcCtD
Fenofibrate—Paraesthesia—Dexamethasone—psoriasis	8.04e-05	0.000246	CcSEcCtD
Fenofibrate—Discomfort—Prednisone—psoriasis	8.03e-05	0.000246	CcSEcCtD
Fenofibrate—Mental disorder—Methotrexate—psoriasis	8.03e-05	0.000246	CcSEcCtD
Fenofibrate—Erythema—Methotrexate—psoriasis	7.98e-05	0.000245	CcSEcCtD
Fenofibrate—Malnutrition—Methotrexate—psoriasis	7.98e-05	0.000245	CcSEcCtD
Fenofibrate—Hypersensitivity—Prednisolone—psoriasis	7.9e-05	0.000242	CcSEcCtD
Fenofibrate—Dyspepsia—Dexamethasone—psoriasis	7.88e-05	0.000242	CcSEcCtD
Fenofibrate—Dyspepsia—Betamethasone—psoriasis	7.88e-05	0.000242	CcSEcCtD
Fenofibrate—Diarrhoea—Mycophenolate mofetil—psoriasis	7.87e-05	0.000241	CcSEcCtD
Fenofibrate—Urticaria—Triamcinolone—psoriasis	7.84e-05	0.00024	CcSEcCtD
Fenofibrate—Body temperature increased—Triamcinolone—psoriasis	7.8e-05	0.000239	CcSEcCtD
Fenofibrate—Dizziness—Cyclosporine—psoriasis	7.8e-05	0.000239	CcSEcCtD
Fenofibrate—Oedema—Prednisone—psoriasis	7.8e-05	0.000239	CcSEcCtD
Fenofibrate—Decreased appetite—Dexamethasone—psoriasis	7.78e-05	0.000239	CcSEcCtD
Fenofibrate—Decreased appetite—Betamethasone—psoriasis	7.78e-05	0.000239	CcSEcCtD
Fenofibrate—Infection—Prednisone—psoriasis	7.74e-05	0.000237	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Betamethasone—psoriasis	7.73e-05	0.000237	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Dexamethasone—psoriasis	7.73e-05	0.000237	CcSEcCtD
Fenofibrate—Back pain—Methotrexate—psoriasis	7.72e-05	0.000237	CcSEcCtD
Fenofibrate—Hypersensitivity—Hydrocortisone—psoriasis	7.72e-05	0.000237	CcSEcCtD
Fenofibrate—Fatigue—Betamethasone—psoriasis	7.72e-05	0.000237	CcSEcCtD
Fenofibrate—Fatigue—Dexamethasone—psoriasis	7.72e-05	0.000237	CcSEcCtD
Fenofibrate—Pain—Dexamethasone—psoriasis	7.66e-05	0.000235	CcSEcCtD
Fenofibrate—Pain—Betamethasone—psoriasis	7.66e-05	0.000235	CcSEcCtD
Fenofibrate—Nervous system disorder—Prednisone—psoriasis	7.65e-05	0.000234	CcSEcCtD
Fenofibrate—Tachycardia—Prednisone—psoriasis	7.61e-05	0.000233	CcSEcCtD
Fenofibrate—Dizziness—Mycophenolate mofetil—psoriasis	7.61e-05	0.000233	CcSEcCtD
Fenofibrate—Skin disorder—Prednisone—psoriasis	7.57e-05	0.000232	CcSEcCtD
Fenofibrate—Hyperhidrosis—Prednisone—psoriasis	7.54e-05	0.000231	CcSEcCtD
Fenofibrate—Asthenia—Hydrocortisone—psoriasis	7.52e-05	0.00023	CcSEcCtD
Fenofibrate—Vomiting—Cyclosporine—psoriasis	7.5e-05	0.00023	CcSEcCtD
Fenofibrate—Rash—Cyclosporine—psoriasis	7.43e-05	0.000228	CcSEcCtD
Fenofibrate—Anorexia—Prednisone—psoriasis	7.43e-05	0.000228	CcSEcCtD
Fenofibrate—Dermatitis—Cyclosporine—psoriasis	7.43e-05	0.000228	CcSEcCtD
Fenofibrate—Pruritus—Hydrocortisone—psoriasis	7.41e-05	0.000227	CcSEcCtD
Fenofibrate—Ill-defined disorder—Methotrexate—psoriasis	7.41e-05	0.000227	CcSEcCtD
Fenofibrate—Headache—Cyclosporine—psoriasis	7.39e-05	0.000226	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—NDUFA5—psoriasis	7.38e-05	0.00121	CbGpPWpGaD
Fenofibrate—Anaemia—Methotrexate—psoriasis	7.38e-05	0.000226	CcSEcCtD
Fenofibrate—Feeling abnormal—Betamethasone—psoriasis	7.38e-05	0.000226	CcSEcCtD
Fenofibrate—Feeling abnormal—Dexamethasone—psoriasis	7.38e-05	0.000226	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Betamethasone—psoriasis	7.32e-05	0.000224	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Dexamethasone—psoriasis	7.32e-05	0.000224	CcSEcCtD
Fenofibrate—Vomiting—Mycophenolate mofetil—psoriasis	7.31e-05	0.000224	CcSEcCtD
Fenofibrate—Hypersensitivity—Triamcinolone—psoriasis	7.27e-05	0.000223	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—VDR—psoriasis	7.26e-05	0.00119	CbGpPWpGaD
Fenofibrate—Rash—Mycophenolate mofetil—psoriasis	7.25e-05	0.000222	CcSEcCtD
Fenofibrate—Dermatitis—Mycophenolate mofetil—psoriasis	7.24e-05	0.000222	CcSEcCtD
Fenofibrate—Headache—Mycophenolate mofetil—psoriasis	7.2e-05	0.000221	CcSEcCtD
Fenofibrate—Malaise—Methotrexate—psoriasis	7.2e-05	0.000221	CcSEcCtD
Fenofibrate—Vertigo—Methotrexate—psoriasis	7.17e-05	0.00022	CcSEcCtD
Fenofibrate—Diarrhoea—Hydrocortisone—psoriasis	7.17e-05	0.00022	CcSEcCtD
Fenofibrate—Leukopenia—Methotrexate—psoriasis	7.15e-05	0.000219	CcSEcCtD
Fenofibrate—Urticaria—Dexamethasone—psoriasis	7.11e-05	0.000218	CcSEcCtD
Fenofibrate—Urticaria—Betamethasone—psoriasis	7.11e-05	0.000218	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Prednisone—psoriasis	7.1e-05	0.000218	CcSEcCtD
Fenofibrate—Dizziness—Prednisolone—psoriasis	7.09e-05	0.000217	CcSEcCtD
Fenofibrate—Asthenia—Triamcinolone—psoriasis	7.08e-05	0.000217	CcSEcCtD
Fenofibrate—Abdominal pain—Dexamethasone—psoriasis	7.08e-05	0.000217	CcSEcCtD
Fenofibrate—Body temperature increased—Betamethasone—psoriasis	7.08e-05	0.000217	CcSEcCtD
Fenofibrate—Abdominal pain—Betamethasone—psoriasis	7.08e-05	0.000217	CcSEcCtD
Fenofibrate—Body temperature increased—Dexamethasone—psoriasis	7.08e-05	0.000217	CcSEcCtD
Fenofibrate—Insomnia—Prednisone—psoriasis	7.05e-05	0.000216	CcSEcCtD
Fenofibrate—Nausea—Cyclosporine—psoriasis	7e-05	0.000215	CcSEcCtD
Fenofibrate—Paraesthesia—Prednisone—psoriasis	7e-05	0.000215	CcSEcCtD
Fenofibrate—Pruritus—Triamcinolone—psoriasis	6.98e-05	0.000214	CcSEcCtD
Fenofibrate—Cough—Methotrexate—psoriasis	6.97e-05	0.000214	CcSEcCtD
Fenofibrate—Dizziness—Hydrocortisone—psoriasis	6.93e-05	0.000212	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.89e-05	0.00113	CbGpPWpGaD
Fenofibrate—Dyspepsia—Prednisone—psoriasis	6.86e-05	0.00021	CcSEcCtD
Fenofibrate—Nausea—Mycophenolate mofetil—psoriasis	6.83e-05	0.000209	CcSEcCtD
Fenofibrate—Chest pain—Methotrexate—psoriasis	6.8e-05	0.000208	CcSEcCtD
Fenofibrate—Myalgia—Methotrexate—psoriasis	6.8e-05	0.000208	CcSEcCtD
Fenofibrate—Arthralgia—Methotrexate—psoriasis	6.8e-05	0.000208	CcSEcCtD
Fenofibrate—Decreased appetite—Prednisone—psoriasis	6.78e-05	0.000208	CcSEcCtD
Fenofibrate—Rash—Prednisolone—psoriasis	6.76e-05	0.000207	CcSEcCtD
Fenofibrate—Dermatitis—Prednisolone—psoriasis	6.76e-05	0.000207	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—NFKB1—psoriasis	6.76e-05	0.0011	CbGpPWpGaD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	6.75e-05	0.000207	CcSEcCtD
Fenofibrate—Fatigue—Prednisone—psoriasis	6.72e-05	0.000206	CcSEcCtD
Fenofibrate—Headache—Prednisolone—psoriasis	6.72e-05	0.000206	CcSEcCtD
Fenofibrate—Discomfort—Methotrexate—psoriasis	6.71e-05	0.000206	CcSEcCtD
Fenofibrate—Constipation—Prednisone—psoriasis	6.67e-05	0.000204	CcSEcCtD
Fenofibrate—Vomiting—Hydrocortisone—psoriasis	6.66e-05	0.000204	CcSEcCtD
Fenofibrate—Rash—Hydrocortisone—psoriasis	6.61e-05	0.000203	CcSEcCtD
Fenofibrate—Dermatitis—Hydrocortisone—psoriasis	6.6e-05	0.000202	CcSEcCtD
Fenofibrate—Headache—Hydrocortisone—psoriasis	6.56e-05	0.000201	CcSEcCtD
Fenofibrate—Dizziness—Triamcinolone—psoriasis	6.52e-05	0.0002	CcSEcCtD
Fenofibrate—Infection—Methotrexate—psoriasis	6.47e-05	0.000198	CcSEcCtD
Fenofibrate—Feeling abnormal—Prednisone—psoriasis	6.42e-05	0.000197	CcSEcCtD
Fenofibrate—Asthenia—Betamethasone—psoriasis	6.42e-05	0.000197	CcSEcCtD
Fenofibrate—Asthenia—Dexamethasone—psoriasis	6.42e-05	0.000197	CcSEcCtD
Fenofibrate—Nervous system disorder—Methotrexate—psoriasis	6.39e-05	0.000196	CcSEcCtD
Fenofibrate—Thrombocytopenia—Methotrexate—psoriasis	6.38e-05	0.000196	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Prednisone—psoriasis	6.37e-05	0.000195	CcSEcCtD
Fenofibrate—Nausea—Prednisolone—psoriasis	6.37e-05	0.000195	CcSEcCtD
Fenofibrate—Pruritus—Betamethasone—psoriasis	6.33e-05	0.000194	CcSEcCtD
Fenofibrate—Pruritus—Dexamethasone—psoriasis	6.33e-05	0.000194	CcSEcCtD
Fenofibrate—Skin disorder—Methotrexate—psoriasis	6.33e-05	0.000194	CcSEcCtD
Fenofibrate—Hyperhidrosis—Methotrexate—psoriasis	6.3e-05	0.000193	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—CYP2S1—psoriasis	6.28e-05	0.00103	CbGpPWpGaD
Fenofibrate—Vomiting—Triamcinolone—psoriasis	6.27e-05	0.000192	CcSEcCtD
Fenofibrate—Nausea—Hydrocortisone—psoriasis	6.22e-05	0.000191	CcSEcCtD
Fenofibrate—Rash—Triamcinolone—psoriasis	6.22e-05	0.000191	CcSEcCtD
Fenofibrate—Dermatitis—Triamcinolone—psoriasis	6.21e-05	0.000191	CcSEcCtD
Fenofibrate—Anorexia—Methotrexate—psoriasis	6.21e-05	0.00019	CcSEcCtD
Fenofibrate—Urticaria—Prednisone—psoriasis	6.19e-05	0.00019	CcSEcCtD
Fenofibrate—Headache—Triamcinolone—psoriasis	6.18e-05	0.000189	CcSEcCtD
Fenofibrate—Body temperature increased—Prednisone—psoriasis	6.16e-05	0.000189	CcSEcCtD
Fenofibrate—Abdominal pain—Prednisone—psoriasis	6.16e-05	0.000189	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—VEGFA—psoriasis	6.13e-05	0.001	CbGpPWpGaD
Fenofibrate—Diarrhoea—Dexamethasone—psoriasis	6.12e-05	0.000188	CcSEcCtD
Fenofibrate—Diarrhoea—Betamethasone—psoriasis	6.12e-05	0.000188	CcSEcCtD
Fenofibrate—Hypotension—Methotrexate—psoriasis	6.09e-05	0.000187	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—STAT3—psoriasis	6.07e-05	0.000993	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NDUFA5—psoriasis	6.01e-05	0.000983	CbGpPWpGaD
Fenofibrate—Musculoskeletal discomfort—Methotrexate—psoriasis	5.94e-05	0.000182	CcSEcCtD
Fenofibrate—Dizziness—Dexamethasone—psoriasis	5.92e-05	0.000181	CcSEcCtD
Fenofibrate—Dizziness—Betamethasone—psoriasis	5.92e-05	0.000181	CcSEcCtD
Fenofibrate—Insomnia—Methotrexate—psoriasis	5.89e-05	0.000181	CcSEcCtD
Fenofibrate—Nausea—Triamcinolone—psoriasis	5.86e-05	0.00018	CcSEcCtD
Fenofibrate—Paraesthesia—Methotrexate—psoriasis	5.85e-05	0.000179	CcSEcCtD
Fenofibrate—PPARA—Metabolism—CAT—psoriasis	5.82e-05	0.000951	CbGpPWpGaD
Fenofibrate—Dyspnoea—Methotrexate—psoriasis	5.81e-05	0.000178	CcSEcCtD
Fenofibrate—Somnolence—Methotrexate—psoriasis	5.79e-05	0.000178	CcSEcCtD
Fenofibrate—Hypersensitivity—Prednisone—psoriasis	5.74e-05	0.000176	CcSEcCtD
Fenofibrate—Dyspepsia—Methotrexate—psoriasis	5.74e-05	0.000176	CcSEcCtD
Fenofibrate—Vomiting—Dexamethasone—psoriasis	5.69e-05	0.000174	CcSEcCtD
Fenofibrate—Vomiting—Betamethasone—psoriasis	5.69e-05	0.000174	CcSEcCtD
Fenofibrate—Decreased appetite—Methotrexate—psoriasis	5.66e-05	0.000174	CcSEcCtD
Fenofibrate—Rash—Betamethasone—psoriasis	5.64e-05	0.000173	CcSEcCtD
Fenofibrate—Rash—Dexamethasone—psoriasis	5.64e-05	0.000173	CcSEcCtD
Fenofibrate—Dermatitis—Betamethasone—psoriasis	5.64e-05	0.000173	CcSEcCtD
Fenofibrate—Dermatitis—Dexamethasone—psoriasis	5.64e-05	0.000173	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Methotrexate—psoriasis	5.62e-05	0.000172	CcSEcCtD
Fenofibrate—Fatigue—Methotrexate—psoriasis	5.62e-05	0.000172	CcSEcCtD
Fenofibrate—Headache—Dexamethasone—psoriasis	5.61e-05	0.000172	CcSEcCtD
Fenofibrate—Headache—Betamethasone—psoriasis	5.61e-05	0.000172	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.6e-05	0.000916	CbGpPWpGaD
Fenofibrate—Asthenia—Prednisone—psoriasis	5.59e-05	0.000171	CcSEcCtD
Fenofibrate—Pain—Methotrexate—psoriasis	5.57e-05	0.000171	CcSEcCtD
Fenofibrate—Pruritus—Prednisone—psoriasis	5.52e-05	0.000169	CcSEcCtD
Fenofibrate—Feeling abnormal—Methotrexate—psoriasis	5.37e-05	0.000165	CcSEcCtD
Fenofibrate—Diarrhoea—Prednisone—psoriasis	5.33e-05	0.000164	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Methotrexate—psoriasis	5.33e-05	0.000163	CcSEcCtD
Fenofibrate—Nausea—Betamethasone—psoriasis	5.32e-05	0.000163	CcSEcCtD
Fenofibrate—Nausea—Dexamethasone—psoriasis	5.32e-05	0.000163	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—TNF—psoriasis	5.26e-05	0.000859	CbGpPWpGaD
Fenofibrate—Urticaria—Methotrexate—psoriasis	5.18e-05	0.000159	CcSEcCtD
Fenofibrate—Dizziness—Prednisone—psoriasis	5.16e-05	0.000158	CcSEcCtD
Fenofibrate—Abdominal pain—Methotrexate—psoriasis	5.15e-05	0.000158	CcSEcCtD
Fenofibrate—Body temperature increased—Methotrexate—psoriasis	5.15e-05	0.000158	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—CYP2S1—psoriasis	5.11e-05	0.000836	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—PPARG—psoriasis	5.06e-05	0.000828	CbGpPWpGaD
Fenofibrate—Vomiting—Prednisone—psoriasis	4.96e-05	0.000152	CcSEcCtD
Fenofibrate—Rash—Prednisone—psoriasis	4.92e-05	0.000151	CcSEcCtD
Fenofibrate—Dermatitis—Prednisone—psoriasis	4.91e-05	0.000151	CcSEcCtD
Fenofibrate—Headache—Prednisone—psoriasis	4.88e-05	0.00015	CcSEcCtD
Fenofibrate—Hypersensitivity—Methotrexate—psoriasis	4.8e-05	0.000147	CcSEcCtD
Fenofibrate—Asthenia—Methotrexate—psoriasis	4.67e-05	0.000143	CcSEcCtD
Fenofibrate—Nausea—Prednisone—psoriasis	4.63e-05	0.000142	CcSEcCtD
Fenofibrate—Pruritus—Methotrexate—psoriasis	4.61e-05	0.000141	CcSEcCtD
Fenofibrate—PPARA—Metabolism—APOE—psoriasis	4.52e-05	0.000739	CbGpPWpGaD
Fenofibrate—Diarrhoea—Methotrexate—psoriasis	4.46e-05	0.000137	CcSEcCtD
Fenofibrate—Dizziness—Methotrexate—psoriasis	4.31e-05	0.000132	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—IL6—psoriasis	4.24e-05	0.000694	CbGpPWpGaD
Fenofibrate—Vomiting—Methotrexate—psoriasis	4.14e-05	0.000127	CcSEcCtD
Fenofibrate—Rash—Methotrexate—psoriasis	4.11e-05	0.000126	CcSEcCtD
Fenofibrate—Dermatitis—Methotrexate—psoriasis	4.1e-05	0.000126	CcSEcCtD
Fenofibrate—Headache—Methotrexate—psoriasis	4.08e-05	0.000125	CcSEcCtD
Fenofibrate—CYP3A4—Metabolism—NDUFA5—psoriasis	3.96e-05	0.000648	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PPARG—psoriasis	3.94e-05	0.000644	CbGpPWpGaD
Fenofibrate—Nausea—Methotrexate—psoriasis	3.87e-05	0.000119	CcSEcCtD
Fenofibrate—CYP3A4—Metabolism—CYP2S1—psoriasis	3.37e-05	0.000551	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.29e-05	0.000538	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CARM1—psoriasis	3.07e-05	0.000501	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.87e-05	0.000469	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.68e-05	0.000438	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CARM1—psoriasis	2.5e-05	0.000408	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.33e-05	0.000381	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CAT—psoriasis	1.89e-05	0.000308	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CARM1—psoriasis	1.65e-05	0.000269	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CAT—psoriasis	1.53e-05	0.000251	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—APOE—psoriasis	1.47e-05	0.00024	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PPARG—psoriasis	1.28e-05	0.000209	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—APOE—psoriasis	1.19e-05	0.000195	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PPARG—psoriasis	1.04e-05	0.00017	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CAT—psoriasis	1.01e-05	0.000166	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—APOE—psoriasis	7.87e-06	0.000129	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PPARG—psoriasis	6.85e-06	0.000112	CbGpPWpGaD
